Related Experiment Videos
Death, depression, and heart disease
S P Roose1, G W Dalack, S Woodring
1Department of Psychiatry, College of Physicians and Surgeons, Columbia University, New York, N.Y.
Insights
Depression significantly impacts cardiac disease prognosis and requires safe treatment strategies. This study examines the concurrence, effects, and management of depression in cardiac patients.
Area of Science:
- Cardiology
- Psychiatry
- Psychosomatic Medicine
Background:
- A complex relationship exists between affective disorders and cardiac disease.
- Understanding this link is crucial for patient outcomes.
- Focus is on depressed patients with pre-existing cardiac conditions.
Purpose of the Study:
- To determine the concurrence rates of depression and cardiac disease.
- To analyze the impact of affective disorder on cardiac prognosis.
- To outline safe and effective depression treatment for cardiac patients.
Main Methods:
- Review of existing literature on affective disorder and cardiac disease.
- Analysis of epidemiological data on co-occurrence.
- Evaluation of treatment guidelines and clinical evidence.
Main Results:
- High rates of co-occurrence between depression and cardiac disease observed.
- Affective disorder negatively influences cardiac disease prognosis.
- Specific pharmacologic and non-pharmacologic treatments are identified as safe and effective.
Conclusions:
- Depression is a significant comorbidity in cardiac patients.
- Managing depression is essential for improving cardiac outcomes.
- Integrated care models are recommended for optimal patient management.
Abstract:
A complex multidimensional relationship exists between affective disorder and cardiac disease, specifically with respect to pathophysiology, prognosis, and treatment. Though there are a number of possible perspectives from which to view this relationship, in this paper we concentrate on the depressed patient with preexisting cardiac disease with respect to (1) the rates of concurrence of the two disorders, (2) the influence of affective disorder on the prognosis of cardiac disease, and (3) the safe and effective treatment of depression in patients with preexisting illness.